Redhill Biopharma (RDHL)
(Delayed Data from NSDQ)
$1.16 USD
-0.01 (-0.85%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $1.08 -0.08 (-6.90%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Market Cap
As of the previous market close, Redhill Biopharma Ltd. has a market cap of $2.69M, which represents its share price of $1.17 multiplied by its outstanding shares number of 2.30M. As a small-cap company, RDHL's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
RDHL 1.16 -0.01(-0.85%)
Will RDHL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for RDHL based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for RDHL
12 Health Care Stocks Moving In Monday's Intraday Session
RedHill (RDHL) Advances RHB-204 Trial with FDA Support | RDHL Stock News
RedHill Receives Positive FDA Feedback on Pathway to Approval of Groundbreaking RHB-204 for ...
RedHill Biopharma receives positive FDA feedback for RHB-204 in Crohn's Disease
12 Health Care Stocks Moving In Friday's Intraday Session